Real-time Estimate Cboe Europe 11:59:03 28/06/2024 BST 5-day change 1st Jan Change
66.52 SEK +0.57% Intraday chart for Elekta AB -0.75% -19.16%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Deutsche Bank Starts Elekta Coverage at Hold MT
ELEKTA : Q4 miss spooked the markets Alphavalue
Elekta AB Provides Financial Guidance for the First Half, Second Half and Full Year of Fiscal Year 2025 CI
Transcript : Elekta AB, 2024 Earnings Call, Jun 05, 2024
Elekta AB Reports Earnings Results for the Full Year Ended April 30, 2024 CI
Elekta AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2024 CI
Elekta Launches AI-Powered, Adaptive CT-Linac for Next Level Cancer Care CI
Elekta to Buy Philips Healthcare's Treatment Planning Patent Portfolio MT
Elekta, GE HealthCare Team Up for New Cancer Treatment Planning Services MT
Elekta and MIM Software Inc. Announce Collaboration to Combine Best-Of-Breed Solutions for Advanced Treatment Planning in the Delivery of Radiation Therapy CI
ELEKTA : Elekta’s attractiveness reinforced Alphavalue
Elekta AB Announces Resignation of Kelly Londy, Member of the Board CI
ELEKTA : Q3 miss; mid-to-longer term prospects remain promising Alphavalue
Transcript : Elekta AB, Q3 2024 Earnings Call, Feb 29, 2024
Elekta AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
Nordic Stocks Closed Down Wednesday; Sinch Took Biggest Hit DJ
Nordic Shares Decreased Tuesday; Sinch Took Biggest Hit DJ
Elekta and Bristol Myers Squibb Partner on Digital Solution for Patients with Melanoma CI
Elekta, Bristol Myers Squibb Collaborate on Digital Platform for Melanoma Patients MT
Nordic Shares Closed Up Thursday; Autostore Holdings Topped Leaders DJ
ELEKTA : Another quarterly beat; but market disappointment with the Q3 outlook Alphavalue
European shares scale 2-mth high on energy, financial boost; eye strong monthly gains RE
Transcript : Elekta AB, Q2 2024 Earnings Call, Nov 30, 2023
Elekta AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023 CI
Elekta Receives Order for Approximately USD 40 Million from KIMS Hyderabad CI
Chart Elekta AB
More charts
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
66.15 SEK
Average target price
76.38 SEK
Spread / Average Target
+15.47%
Consensus
  1. Stock Market
  2. Equities
  3. EKTA B Stock
  4. News Elekta AB
  5. Deutsche Bank Starts Elekta Coverage at Hold